Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Identification of small molecules that interfere with H1N1 influenza A viral replication.

Bottini A, De SK, Baaten BJ, Wu B, Barile E, Soonthornvacharin S, Stebbins JL, Bradley LM, Chanda SK, Pellecchia M.

ChemMedChem. 2012 Dec;7(12):2227-35. doi: 10.1002/cmdc.201200453. Epub 2012 Nov 8.

2.

Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses.

Kumar N, Sharma NR, Ly H, Parslow TG, Liang Y.

Antimicrob Agents Chemother. 2011 Dec;55(12):5553-9. doi: 10.1128/AAC.00725-11. Epub 2011 Sep 19.

3.

Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen.

Maddry JA, Chen X, Jonsson CB, Ananthan S, Hobrath J, Smee DF, Noah JW, Noah D, Xu X, Jia F, Maddox C, Sosa MI, White EL, Severson WE.

J Biomol Screen. 2011 Jan;16(1):73-81. doi: 10.1177/1087057110384613. Epub 2010 Nov 8.

PMID:
21059874
4.

Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.

Yuan S, Chu H, Zhao H, Zhang K, Singh K, Chow BK, Kao RY, Zhou J, Zheng BJ.

Antiviral Res. 2016 Jan;125:34-42. doi: 10.1016/j.antiviral.2015.11.005. Epub 2015 Nov 22.

PMID:
26593979
5.

[In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].

Shishkina LN, Nebol'sin VE, Skarnovich MO, Kabanov AS, Sergeev AA, Erdyneeva UB, Serova OA, Demina OK, Agafonov AP, Stavskiĭ EA, Drozdov IG.

Antibiot Khimioter. 2010;55(5-6):32-5. Russian.

PMID:
21033472
6.

Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus.

Hsieh CF, Lo CW, Liu CH, Lin S, Yen HR, Lin TY, Horng JT.

J Ethnopharmacol. 2012 Aug 30;143(1):57-67. doi: 10.1016/j.jep.2012.05.061. Epub 2012 Jun 16.

PMID:
22710290
7.

Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.

Haasbach E, Pauli EK, Spranger R, Mitzner D, Schubert U, Kircheis R, Planz O.

Antiviral Res. 2011 Sep;91(3):304-13. doi: 10.1016/j.antiviral.2011.07.006. Epub 2011 Jul 13.

PMID:
21777621
8.

Targeting organic anion transporter 3 with probenecid as a novel anti-influenza a virus strategy.

Perwitasari O, Yan X, Johnson S, White C, Brooks P, Tompkins SM, Tripp RA.

Antimicrob Agents Chemother. 2013 Jan;57(1):475-83. doi: 10.1128/AAC.01532-12. Epub 2012 Nov 5.

9.

Germacrone inhibits early stages of influenza virus infection.

Liao Q, Qian Z, Liu R, An L, Chen X.

Antiviral Res. 2013 Dec;100(3):578-88. doi: 10.1016/j.antiviral.2013.09.021. Epub 2013 Oct 3.

PMID:
24095670
10.

[Colletodiol inhibits the replication of influenza A virus WSN/H1N1 by reducing the activity of viral RNA polymerase].

Lai W, Wang S, Ye X.

Wei Sheng Wu Xue Bao. 2013 Dec 4;53(12):1334-9. Chinese.

PMID:
24697106
11.

Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection.

Conti G, Magliani W, Conti S, Nencioni L, Sgarbanti R, Palamara AT, Polonelli L.

Antimicrob Agents Chemother. 2008 Dec;52(12):4331-7. doi: 10.1128/AAC.00506-08. Epub 2008 Sep 29.

12.

Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.

Onishi M, Kitano M, Taniguchi K, Homma T, Kobayashi M, Yoshinaga T, Naito A, Sato A.

Antiviral Res. 2015 May;117:52-9. doi: 10.1016/j.antiviral.2015.02.012. Epub 2015 Mar 6.

PMID:
25752738
13.

Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine.

Liu Z, Zhao J, Li W, Shen L, Huang S, Tang J, Duan J, Fang F, Huang Y, Chang H, Chen Z, Zhang R.

Sci Rep. 2016 Jan 12;6:19095. doi: 10.1038/srep19095.

14.

Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate.

Wiesener N, Zimmer C, Jarasch-Althof N, Wutzler P, Henke A.

Med Microbiol Immunol. 2011 May;200(2):115-26. doi: 10.1007/s00430-010-0182-x. Epub 2010 Dec 21.

PMID:
21174118
15.

A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon.

Ortigoza MB, Dibben O, Maamary J, Martinez-Gil L, Leyva-Grado VH, Abreu P Jr, Ayllon J, Palese P, Shaw ML.

PLoS Pathog. 2012;8(4):e1002668. doi: 10.1371/journal.ppat.1002668. Epub 2012 Apr 26.

16.

Anti-influenza virus effect of aqueous extracts from dandelion.

He W, Han H, Wang W, Gao B.

Virol J. 2011 Dec 14;8:538. doi: 10.1186/1743-422X-8-538.

17.

Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity.

Mazur I, Wurzer WJ, Ehrhardt C, Pleschka S, Puthavathana P, Silberzahn T, Wolff T, Planz O, Ludwig S.

Cell Microbiol. 2007 Jul;9(7):1683-94. Epub 2007 Feb 23.

PMID:
17324159
18.

Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.

Haasbach E, Droebner K, Vogel AB, Planz O.

J Interferon Cytokine Res. 2011 Jun;31(6):515-25. doi: 10.1089/jir.2010.0071. Epub 2011 Feb 16.

PMID:
21323570
19.

Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.

Kocik J, Kołodziej M, Joniec J, Kwiatek M, Bartoszcze M.

Acta Biochim Pol. 2014;61(3):509-13. Epub 2014 Sep 12.

20.

Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection.

Bahgat MM, Błazejewska P, Schughart K.

Virol J. 2011 Jan 20;8:27. doi: 10.1186/1743-422X-8-27.

Supplemental Content

Support Center